India Launches One Health AMR Challenge to Combat Drug Resistance across Sectors

The Centre for Cellular and Molecular Platforms, supported by India's Department of Biotechnology, has unveiled the One Health AMR Challenge 2025 to address Antimicrobial Resistance in humans, animals, and the environment. This challenge aims to scale promising technologies with support ranging from funding to market-readiness assistance.


Devdiscourse News Desk | Bengaluru | Updated: 07-07-2025 14:52 IST | Created: 07-07-2025 14:52 IST
India Launches One Health AMR Challenge to Combat Drug Resistance across Sectors
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.
  • Country:
  • India

The One Health AMR Challenge 2025 has been launched by the Centre for Cellular and Molecular Platforms (C-CAMP) in association with the Department of Biotechnology, Government of India. This groundbreaking initiative targets Antimicrobial Resistance (AMR) across humans, animals, and the environment.

The challenge was officially inaugurated by Prof Ajay Sood, Principal Scientific Adviser to the Government, during the India AMR Innovation workshop at C-CAMP's Bengaluru campus. Sood emphasized the importance of integrating human, animal, and environmental health under India's 'One Health' approach to effectively combat AMR.

C-CAMP aims to identify and support up to 12 advanced-stage technologies ready for market deployment with funding between USD 50,000 to 250,000. Beyond financing, the winners will gain access to technical assistance, enhancing their readiness for regulatory, legal, and manufacturing challenges. The initiative also receives backing from ICARS, with applications closing on August 3.

(With inputs from agencies.)

Give Feedback